Avecho Biotechnology Limited (OEZ) — Cash Flow-to-Debt Ratio
Avecho Biotechnology Limited (OEZ) has a Cash Flow-to-Debt Ratio of -0.88x as of December 2022, meaning its operating cash flow of €-808.80K could theoretically repay -1% of its total liabilities (€920.66K) in one year. See OEZ cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Avecho Biotechnology Limited Cash Flow-to-Debt Ratio (2013–2022)
Historical debt coverage capacity for Avecho Biotechnology Limited across 10 annual periods. Also explore OEZ shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Avecho Biotechnology Limited (2013–2022)
Year-by-year debt coverage analysis for Avecho Biotechnology Limited. For market capitalisation and broader financial context, see OEZ market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.81x | €-1.67 Million | €920.66K | ▲ +58.6% |
| 2021 | -4.37x | €-3.10 Million | €709.36K | ▼ -114.8% |
| 2020 | -2.03x | €-1.42 Million | €700.17K | ▼ -196.0% |
| 2019 | 2.12x | €1.18 Million | €556.12K | ▲ +187.3% |
| 2018 | -2.43x | €-2.19 Million | €902.04K | ▲ +30.7% |
| 2017 | -3.50x | €-6.42 Million | €1.84 Million | ▲ +6.9% |
| 2016 | -3.76x | €-6.41 Million | €1.71 Million | ▲ +21.6% |
| 2015 | -4.79x | €-8.71 Million | €1.82 Million | ▼ -33.2% |
| 2014 | -3.60x | €-6.74 Million | €1.87 Million | ▲ +8.3% |
| 2013 | -3.92x | €-8.58 Million | €2.19 Million | — |